Some patients seeking treatment outside hospitals can now use the antiviral remdesivir after U.S. drug regulators late Friday expanded approval of the drug. The Food and Drug Administration (FDA) said the expansion was supported by a study run by Gilead Sciences, which developed remdesivir, showing the drug cut the risk of hospitalization by 87 percent…